Cargando…

Mitochondrial Agents for Bipolar Disorder

BACKGROUND: Bipolar disorder is a chronic and often debilitating illness. Current treatment options (both pharmaco- and psychotherapy) have shown efficacy, but for many leave a shortfall in recovery. Advances in the understanding of the pathophysiology of bipolar disorder suggest that interventions...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pereira, Círia, Chavarria, Victor, Vian, João, Ashton, Melanie Maree, Berk, Michael, Marx, Wolfgang, Dean, Olivia May
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007750/ https://www.ncbi.nlm.nih.gov/pubmed/29596661 http://dx.doi.org/10.1093/ijnp/pyy018

Ejemplares similares

Does Post-traumatic Stress Disorder Impact Treatment Outcomes within a Randomised Controlled Trial of Mitochondrial Agents for Bipolar Depression?
por: Russell, Samantha E., et al.
Publicado: (2023)

The renin–angiotensin system: a possible new target for depression
por: Vian, João, et al.
Publicado: (2017)

Nutraceuticals and nutritional supplements for the treatment of bipolar disorder: protocol for a systematic review
por: Ashton, Melanie M, et al.
Publicado: (2019)

The Impact of Posttraumatic Stress Disorder on Pharmacologic Intervention Outcomes for Adults With Bipolar Disorder: A Systematic Review
por: Russell, Samantha E, et al.
Publicado: (2022)

Tobacco Use in Bipolar Disorder
por: Thomson, Daniel, et al.
Publicado: (2015)

The Therapeutic Potential of Mangosteen Pericarp as an Adjunctive Therapy for Bipolar Disorder and Schizophrenia
por: Ashton, Melanie M., et al.
Publicado: (2019)

Mixed Methods Thematic Analysis of a Randomised Controlled Trial of Adjunctive Mitochondrial Agents for Bipolar Depression
por: Russell, Samantha E., et al.
Publicado: (2022)

A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
por: Berk, Michael, et al.
Publicado: (2019)

Correction to: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
por: Berk, Michael, et al.
Publicado: (2019)

Protocol and Rationale-The Efficacy of Minocycline as an Adjunctive Treatment for Major Depressive Disorder: A Double Blind, Randomised, Placebo Controlled Trial
por: Dean, Olivia May, et al.
Publicado: (2014)

The role of lamotrigine in the management of bipolar disorder
por: Ng, Felicity, et al.
Publicado: (2007)

Influence of childhood trauma on the treatment outcomes of pharmacological and/or psychological interventions for adolescents and adults with bipolar disorder: protocol for a systematic review and meta-analysis
por: Wrobel, Anna, et al.
Publicado: (2021)

Staging in bipolar disorder: one step closer to precision psychiatry
por: Fernandes, Brisa S., et al.
Publicado: (2017)

Future Directions for Pharmacotherapies for Treatment-resistant Bipolar Disorder
por: Dodd, Seetal, et al.
Publicado: (2015)

Evaluation of the acceptability and usefulness of an information website for caregivers of people with bipolar disorder
por: Berk, Lesley, et al.
Publicado: (2013)

Mitochondrial Alterations in Fibroblasts of Early Stage Bipolar Disorder Patients
por: Marques, Ana P., et al.
Publicado: (2021)

Role of personality disorder in randomised controlled trials of pharmacological interventions for adults with mood disorders: a protocol for a systematic review and meta-analysis
por: Kavanagh, Bianca E, et al.
Publicado: (2019)

Bipolar At-Risk Criteria and Risk of Bipolar Disorder Over 10 or More Years
por: Ratheesh, Aswin, et al.
Publicado: (2023)

A brief review of exercise, bipolar disorder, and mechanistic pathways
por: Thomson, Daniel, et al.
Publicado: (2015)

Molecular hydrogen: an overview of its neurobiological effects and therapeutic potential for bipolar disorder and schizophrenia
por: Ghanizadeh, Ahmad, et al.
Publicado: (2013)

Toward Precision Psychiatry in Bipolar Disorder: Staging 2.0
por: Salagre, Estela, et al.
Publicado: (2018)

Transcriptional Modulation of the Hippo Signaling Pathway by Drugs Used to Treat Bipolar Disorder and Schizophrenia
por: Panizzutti, Bruna, et al.
Publicado: (2021)

Mitochondrial Health Index Correlates with Plasma Circulating Cell-Free Mitochondrial DNA in Bipolar Disorder
por: Scaini, Giselli, et al.
Publicado: (2023)

The mental health and lifestyle impacts of COVID-19 on bipolar disorder
por: Karantonis, James A., et al.
Publicado: (2021)

Perturbations in the apoptotic pathway and mitochondrial network dynamics in peripheral blood mononuclear cells from bipolar disorder patients
por: Scaini, G, et al.
Publicado: (2017)

Mitochondrial Variants in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
por: Rollins, Brandi, et al.
Publicado: (2009)

Personality disorder and functioning in major depressive disorder: a nested study within a randomized controlled trial
por: Kavanagh, Bianca E., et al.
Publicado: (2019)

Accelerated epigenetic aging and mitochondrial DNA copy number in bipolar disorder
por: Fries, Gabriel R., et al.
Publicado: (2017)

Psychometric Properties of the Chinese Version of the Bipolar Depression Rating Scale for Bipolar Disorder
por: Chen, Jing-Xu, et al.
Publicado: (2021)

Listening to the silent struggles of bipolar disorder through sonification of iMoodJournal data
por: Angeler, David G., et al.
Publicado: (2022)

Impact of Cannabis Use on Long-Term Remission in Bipolar I and Schizoaffective Disorder
por: Kim, Sung-Wan, et al.
Publicado: (2015)

Add-on treatment with N-acetylcysteine for bipolar depression: a 24-week randomized double-blind parallel group placebo-controlled multicentre trial (NACOS-study protocol)
por: Ellegaard, Pernille Kempel, et al.
Publicado: (2018)

Ascending Paralysis in a 36-Year-Old Woman With Bipolar Disorder and Recent Aspiration Pneumonia
por: Varma-Doyle, Aditi Vian, et al.
Publicado: (2020)

Adjunctive minocycline for major depressive disorder: A sub-study exploring peripheral immune-inflammatory markers and associated treatment response
por: Walker, Adam J., et al.
Publicado: (2022)

Attachment insecurity partially mediates the relationship between childhood trauma and depression severity in bipolar disorder
por: Wrobel, Anna L., et al.
Publicado: (2022)

Metabolic regulation to treat bipolar depression: mechanisms and targeting by trimetazidine
por: Khanra, Sourav, et al.
Publicado: (2023)

Co-Expression Networks Unveiled Long Non-Coding RNAs as Molecular Targets of Drugs Used to Treat Bipolar Disorder
por: Truong, Trang TT., et al.
Publicado: (2022)

Systematic Review of Epigenetic Effects of Pharmacological Agents for Bipolar Disorders
por: Lockwood, Laura E., et al.
Publicado: (2017)

Maintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomized placebo controlled trial
por: Berk, Michael, et al.
Publicado: (2012)

The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
por: Morris, Gerwyn, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_gu7homn4d1t5k326h0br46balu